Published on 21 Dec 2023 on GuruFocus.com via Yahoo Finance
Amicus Therapeutics Inc's Chief Development Officer Sells Shares
On December 20, 2023, Jeff Castelli, Chief Development Officer of Amicus Therapeutics Inc (NASDAQ:FOLD), sold 19,154 shares of the company, according to a recent SEC Filing. This transaction was part of the insider's trading activities over the past year, during which the insider sold a total of 19,154 shares and made no purchases.
Warning! GuruFocus has detected 5 Warning Signs with FOLD.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare metabolic diseases. The company's lead product includes therapies for the treatment of Fabry and Pompe disease, as well as programs for other rare and orphan diseases.